Anti-NCK1 antibody
Specifications
| Product Cat#: | AB-06-3062 |
| Product type: | Primary antibody |
| Antigen: | NCK1 |
| Immunogen: | Recombinant protein |
| Species immunized: | Mouse |
| Isotype: | IgG1 |
| Applications: | Western Blot ( 1:400-1:1500 ); Immunofluorescence ( 1:100-1:150 );Immunohistochemistry ( 1:100-1:150 ) |
| Reactivity: | Human, Monkey |
| Clonality (clone number): | Monoclonal ( C2-B7) |
| Form: | Liquid |
| Buffer: | 1*TBS ( pH7.4 ), 1 %BSA, 40 %Glycerol. Preservative: 0.05 % Sodium Azide. |
| Concentration: | 1 mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | Cytoplasmic Protein NCK1 Antibody |
| Melanoma Nck Protein Antibody | |
| MGC12668 Antibody | |
| NCK 1 Antibody | |
| NCK Adaptor Protein 1 Antibody | |
| NCK Alpha Antibody | |
| NCK Antibody | |
| NCK Tyrosine Kinase Antibody | |
| Nck-1 Antibody | |
| NCK1 Antibody | |
| NCK1_HUMANAntibody | |
| NCKalpha Antibody | |
| Non Catalytic Region of Tyrosine Kinase Antibody | |
| SH2/SH3 Adaptor protein NCK alpha Antibody | |
| SH2/SH3 Adaptor protein NCK-alpha Antibody |
Target information
NCK1 couples tyrosine kinase signaling, including the EGF and PDGF receptor-pathways, to downstream signaling proteins. Specifically, overexpression of Nck1 in NIH/3T3 cells decreases DNA synthesis stimulated by EGF. Furthermore, the SH2 domain of NCK2 inhibits EGF- and PDGF-induced DNA synthesis. The SH3 domain of NCK binds a proline-rich domain on PAK, a known actin cytoskeleton regulator. The NCK protein thus mediates the interaction between PAK and RAC. The NCK2 protein binds human PDGFR-b (Tyr 1009); overexpression of Nck2 inhibits PDGF-induced membrane ruffling and lamellipod formation. Various growth factor receptors, cell surface antigens and adhesion molecules phosphorylate mammalian NCK1 and NCK2. The human NCK1 and NCK2 genes map to chromosomes 3q21 and 2q12, respectively.
Provider
Erpantech Laboratory
